V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 10172452 | 10071393 | 1.75 | 66 | Curative (C) | 2019-02-27 | 2019-03-02 | PERTUZUMAB | 02 | null | DOXORUBICIN + OLARATUMAB | 100916754 |
| 10175206 | 10071394 | 1.57 | 0 | null | 2019-12-05 | 2019-12-26 | Durvalumab | N | null | SORAFENIB | 101115525 |
| 10186892 | 10071398 | 1.49 | 74.1 | null | 2018-05-26 | 2018-09-13 | DOCETAXEL + TRASTUZUMAB | 02 | null | FLAIR TRIAL | 100272932 |
| 10189203 | 10071399 | 1.7 | 83 | Palliative (P) | 2022-04-18 | 2022-04-18 | ABEMACICLIB + FULVESTRANT | 02 | N | CYCLOPHOSPHAMIDE + LENALIDOMIDE | 100076185 |
| 10193984 | 10071400 | 1.8 | 0 | Palliative (P) | 2018-10-29 | 2019-03-12 | FCarboSt | null | N | LENVATINIB | 100028567 |
| 10194595 | 10071401 | null | 89 | Curative (C) | 2019-11-18 | 2019-12-12 | CAPECITABINE + TEMOZOLOMIDE | 02 | N | FLUOROURACIL + OXALIPLATIN + PANITUMUMAB | 100647434 |
| 10212602 | 10071405 | 1.56 | 0 | null | 2020-01-12 | 2020-01-12 | THALIDOMIDE | 99 | null | BOSUTINIB | 100779482 |
| 10240488 | 10071408 | 1.6 | 83 | null | 2019-09-22 | 2019-10-19 | CHOP R | 99 | null | ELOQUENT2 TRIAL | 101791713 |
| 10245092 | 10071409 | 1.68 | 52.25 | Curative (C) | 2017-11-18 | 2017-12-01 | Docetaxel + Nintedanib | 02 | N | MELPHALAN + THALIDOMIDE | 100537325 |
| 10257267 | 10071411 | 0 | 70.6 | 03 | 2020-10-14 | 2020-11-01 | TRASTUZUMAB EMTANSINE | 02 | N | STAMPEDE TRIAL | 101351999 |
| 10257579 | 10071412 | null | null | null | 2022-01-28 | 2022-02-08 | PEG INTERFERON | 02 | null | CARBOPLATIN + ETOPOSIDE + IFOSFAMIDE + RITUXIMAB | 101654023 |
| 10277622 | 10071416 | 1.84 | 55 | null | 2022-02-15 | 2022-02-15 | IGEV R | 02 | null | DOXORUBICIN | 100962482 |
| 10280266 | 10071417 | 1.63 | 73 | Curative (C) | 2019-01-09 | 2019-04-08 | Trial Unspecified | 02 | N | CYCLOPHOSPHAMIDE + DOCETAXEL + EPIRUBICIN | 100528963 |
| 10281533 | 10071418 | 1.8 | 88.1 | null | 2020-07-15 | 2020-07-21 | CHOP | 02 | null | CYTARABINE + OXALIPLATIN | 100107109 |
| 10293663 | 10071423 | 1.72 | 87.75 | Palliative (P) | 2021-02-24 | 2021-02-25 | AML 18 TRIAL | 02 | N | CYCLOPHOSPHAMIDE + ETOPOSIDE + RITUXIMAB + VINCRISTINE | 101641490 |
| 10296487 | 10071424 | null | 70 | Palliative (P) | 2018-03-20 | 2018-04-13 | Abemaciclib | null | N | ANAGRELIDE | 100596748 |
| 10297559 | 10071425 | 0 | 0 | 03 | 2019-01-13 | 2020-06-16 | MYELOMA XI TRIAL | N | N | TALIMOGENE LAHERPAREPVEC | 100394923 |
| 10299345 | 10071427 | 1.71 | 69.4 | null | 2022-03-23 | 2022-04-08 | Zanubrutinib | 02 | null | LIPOSOMAL DAUNORUBICIN + LIPOSOMAL CYTARABINE (VYXEOS) | 100047422 |
| 10302602 | 10071429 | 1.82 | 92.6 | null | 2019-09-08 | 2019-12-31 | CYCLOPHOSPHAMIDE + LENALIDOMIDE | 02 | null | CAR-T AXICABTAGENE CILOLEUCEL + CYCLOPHOSPHAMIDE + FLUDARABINE | 100733846 |
| 10335464 | 10071435 | 1.7 | 57.7 | Palliative (P) | 2020-09-05 | 2020-09-07 | null | 02 | N | CYCLOPHOSPHAMIDE + EPIRUBICIN | 100837378 |
| 10336205 | 10071436 | 1.88 | 89.7 | Palliative (P) | null | 2020-07-08 | EOX | 02 | N | BEVACIZUMAB | 101294257 |
| 10337274 | 10071437 | null | null | null | 2019-08-03 | 2019-12-09 | Irinotecan + Modified De Gramont | 02 | null | BOSUTINIB | 100832100 |
| 10341785 | 10071440 | 1.61 | 75.2 | Disease modification (D) | 2020-10-20 | 2020-11-03 | null | 02 | N | CYCLOPHOSPHAMIDE + LENALIDOMIDE | 100988540 |
| 10342392 | 10071442 | 1.65 | 57.7 | null | null | 2018-03-28 | Alemtuz+Fludara+Melphalan RIC MUD | 02 | null | CVD | 100550491 |
| 10347171 | 10071443 | 1.75 | 67.2 | null | 2019-07-13 | 2019-09-09 | Carboplatin + Pembrolizumab + Pemetrexed | 02 | null | NOT MATCHED | 101200589 |
| 10348373 | 10071446 | 0 | 82 | Palliative (P) | 2021-02-13 | 2021-02-13 | FEC | 02 | N | LETROZOLE + RIBOCICLIB | 101246639 |
| 10359844 | 10071451 | 0 | 76.2 | null | 2020-12-07 | 2021-04-16 | Ipilimumab | 02 | null | IPILIMUMAB | 101704836 |
| 10360895 | 10071452 | 1.58 | 52.8 | Palliative (P) | 2018-08-31 | 2018-09-21 | null | 02 | N | IDELALISIB | 101609114 |
| 10362044 | 10071453 | 1.68 | 93.3 | null | 2020-11-02 | 2020-11-02 | Ipilimumab | 02 | null | TRIAL | 101165589 |
| 10366416 | 10071454 | 1.58 | 76.1 | null | 2020-06-12 | 2020-06-12 | null | 02 | N | MYELOMA XI TRIAL | 101417409 |
| 10381938 | 10071456 | 1.77 | 90.4 | null | 2021-05-05 | 2021-05-07 | Brentuximab | 02 | null | CARBOPLATIN + PEMBROLIZUMAB + PEMETREXED | 101748891 |
| 10384782 | 10071457 | 1.84 | 70 | Palliative (P) | 2019-05-04 | 2019-05-04 | Bortezomib + Panobinostat + Thalidomide | 02 | N | OXALIPLATIN + MDG | 100920432 |
| 10388861 | 10071459 | 1.64 | 81.3 | Palliative (P) | 2019-03-17 | 2019-03-17 | Capecitabine + Cisplatin | 02 | N | BEVACIZUMAB | 101616462 |
| 10391097 | 10071460 | 1.67 | 58.5 | Palliative (P) | 2020-08-26 | 2020-08-26 | R GCVP | 02 | N | DOXORUBICIN + OLARATUMAB | 101266589 |
| 10406530 | 10071464 | 0 | 86.5 | null | 2019-01-21 | 2019-01-21 | Capecitabine + Cisplatin + RT | 02 | null | BENDAMUSTINE | 100252882 |
| 10407616 | 10071465 | 1.58 | 73 | Palliative (P) | 2021-03-19 | 2021-03-19 | Bevacizumab | 01 | N | FLUOROURACIL + MITOMYCIN | 100748066 |
| 10407907 | 10071466 | 1.78 | 102.7 | null | 2020-03-05 | 2020-03-05 | Capecitabine + Cisplatin | 02 | null | CYCLOPHOSPHAMIDE + DOXORUBICIN + METHOTREXATE + RITUXIMAB + VINCRISTINE | 100734335 |
| 10410681 | 10071468 | 1.63 | 73.2 | Palliative (P) | 2020-04-18 | 2020-04-18 | ISATUXIMAB + POMALIDOMIDE | 02 | N | CAPECITABINE + GEMCITABINE | 101547218 |
| 10417622 | 10071470 | 1.78 | 85.2 | null | null | 2021-03-13 | ATG + Busulfan + Fludarabine | 02 | null | FCR | 101605680 |
| 10421790 | 10071471 | 1.8 | 106 | Palliative (P) | 2019-08-29 | 2019-09-01 | ALL UKALL60+ TRIAL | 02 | N | IRINOTECAN + MDG | 100885565 |
| 10431345 | 10071473 | 1.7 | 68.2 | Palliative (P) | 2016-08-05 | 2018-02-02 | null | 02 | N | CAPECITABINE + CARBOPLATIN | 101540212 |
| 10432764 | 10071474 | 1.75 | 87.2 | Palliative (P) | 2018-07-09 | 2018-07-22 | Doxorubicin + Olaratumab | 02 | N | BEXAROTENE | 101502651 |
| 10435685 | 10071475 | 1.68 | 76.4 | null | 2016-01-23 | 2019-08-23 | CARFILZOMIB | null | null | AML18 TRIAL | 101680680 |
| 10453660 | 10071478 | 1.47 | 71.4 | null | 2017-02-13 | 2017-02-16 | NAB PACLITAXEL | 02 | null | RUCAPARIB | 101746091 |
| 10475356 | 10071484 | 1.61 | 77.8 | null | null | 2019-09-21 | IDELALISIB + RITUXIMAB | N | null | LOMUSTINE | 100693937 |
| 10231904 | 10071489 | null | null | null | null | 2020-02-07 | CISPLATIN + GEMCITABINE + RITUXIMAB | 99 | N | CISPLATIN + FLUOROURACIL | 101636948 |
| 10349659 | 10071496 | 1.64 | 70 | Palliative (P) | 2019-07-20 | 2019-08-12 | FLAIR trial | 02 | N | OBINUTUZUMAB + VENETOCLAX | 100533354 |
| 10457743 | 10071499 | 1.67 | 75.4 | Palliative (P) | 2022-03-16 | 2022-05-11 | PACLITAXEL + TRASTUZUMAB | 02 | N | ANAGRELIDE | 100085056 |
| 10415019 | 10071806 | 1.7 | 58.4 | null | 2018-09-16 | 2019-01-14 | Rituximab | null | null | RITUXIMAB | 101538179 |
| 10415025 | 10071807 | 1.68 | 62 | 03 | 2021-07-10 | 2021-07-10 | IBRUTINIB | 99 | N | IBRUTINIB | 100424805 |